In the present context of an aging population, limited donor heart availability, improved reliability of mechanical cardiac support and improved patient outcomes, ventricular assist device (VAD) options to support end-stage heart failure patients are rapidly expanding. In addition, both the smaller size and lighter weight of the pumps now produced and early evidence that these third generation devices may be associated with lower risk of infection and right ventricular failure will probably lead to greater physician and patient acceptability. This is the first of a two-part review on the role of cardiovascular prevention and rehabilitation in patients with VAD. In this first part, we will discuss the role of exercise therapy in VAD patients...
Heart failure (HF) continues to be a highly prevalent disease, affecting 1–2% of the population in d...
Chronic heart failure (CHF) is a devastating clinical syndrome. Therapeutic schemes for have develop...
Despite advances in pharmacological treatments aimed at a neurohormonal blockade for heart failure, ...
Over the years left ventricular assist devices (VADs) have become more durable and reliable, smaller...
[Abstract] Exercise training (ET) and secondary prevention measures in cardiovascular disease ai...
The need for mechanical assistance of the failing heart, whether acute after a myocardial infarction...
Exercise training (ET) and secondary prevention measures in cardiovascular disease aim to stimulate ...
Aims Left ventricular assist device (LVAD) therapy is a promising option for patients with advanced...
An increasing number of patients with end-stage heart failure are being treated with continuous-flow...
Exercise training (ET) and secondary prevention measures in cardiovascular disease aim to stimulate ...
A left ventricular assist device (LVAD) is a mechanical circulation support implanted for patients w...
Heart failure remains one of the most common causes of morbidity and mortality worldwide. The advent...
The efficacy of cardiac rehabilitation in heart-failure patients who received a left-ventricular ass...
AbstractLeft ventricular assist devices are becoming an increasingly prevalent therapy for patients ...
Mechanical cardiac circulatory support has been established as a benefactory treatment modality for ...
Heart failure (HF) continues to be a highly prevalent disease, affecting 1–2% of the population in d...
Chronic heart failure (CHF) is a devastating clinical syndrome. Therapeutic schemes for have develop...
Despite advances in pharmacological treatments aimed at a neurohormonal blockade for heart failure, ...
Over the years left ventricular assist devices (VADs) have become more durable and reliable, smaller...
[Abstract] Exercise training (ET) and secondary prevention measures in cardiovascular disease ai...
The need for mechanical assistance of the failing heart, whether acute after a myocardial infarction...
Exercise training (ET) and secondary prevention measures in cardiovascular disease aim to stimulate ...
Aims Left ventricular assist device (LVAD) therapy is a promising option for patients with advanced...
An increasing number of patients with end-stage heart failure are being treated with continuous-flow...
Exercise training (ET) and secondary prevention measures in cardiovascular disease aim to stimulate ...
A left ventricular assist device (LVAD) is a mechanical circulation support implanted for patients w...
Heart failure remains one of the most common causes of morbidity and mortality worldwide. The advent...
The efficacy of cardiac rehabilitation in heart-failure patients who received a left-ventricular ass...
AbstractLeft ventricular assist devices are becoming an increasingly prevalent therapy for patients ...
Mechanical cardiac circulatory support has been established as a benefactory treatment modality for ...
Heart failure (HF) continues to be a highly prevalent disease, affecting 1–2% of the population in d...
Chronic heart failure (CHF) is a devastating clinical syndrome. Therapeutic schemes for have develop...
Despite advances in pharmacological treatments aimed at a neurohormonal blockade for heart failure, ...